{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:35:26Z","timestamp":1781163326709,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014707","name":"Society for the Study of Theology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020406","name":"Dr. Falk Pharma","doi-asserted-by":"publisher","award":["91718300"],"award-info":[{"award-number":["91718300"]}],"id":[{"id":"10.13039\/501100020406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.iac.2023.12.011","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T20:40:54Z","timestamp":1707338454000},"page":"265-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Health-Related Quality of Life in Patients with Eosinophilic Esophagitis"],"prefix":"10.1016","volume":"44","author":[{"given":"Maria L.","family":"van Klink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Bredenoord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2023.12.011_bib1","doi-asserted-by":"crossref","unstructured":"Kuyken W.G., The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization, Soc Sci Med, 41 (10), 1995, 1403\u20131409.","DOI":"10.1016\/0277-9536(95)00112-K"},{"key":"10.1016\/j.iac.2023.12.011_bib2","unstructured":"World Health Organization, he first ten years of the World Health, In: Organization,\u00a01958,\u00a0World Health Organization;\u00a0Geneva."},{"issue":"1","key":"10.1016\/j.iac.2023.12.011_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tcmj.2012.09.002","article-title":"Methodological issues in measuring health-related quality of life","volume":"25","author":"Lin","year":"2013","journal-title":"Tzu Chi Med J"},{"issue":"11","key":"10.1016\/j.iac.2023.12.011_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","article-title":"Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) Project","volume":"51","author":"Ware","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3 Suppl","key":"10.1016\/j.iac.2023.12.011_bib5","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1097\/00005650-198903001-00018","article-title":"Generic and disease-specific measures in assessing health status and quality of life","volume":"27","author":"Patrick","year":"1989","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.iac.2023.12.011_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.iac.2023.12.011_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.12968\/hmed.2019.80.3.132","article-title":"Overview of eosinophilic oesophagitis","volume":"80","author":"Attwood","year":"2019","journal-title":"Br J Hosp Med"},{"issue":"13","key":"10.1016\/j.iac.2023.12.011_bib8","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2021.14920","article-title":"Eosinophilic esophagitis: a review","volume":"326","author":"Muir","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.iac.2023.12.011_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.iac.2023.12.011_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41395-018-0052-5","article-title":"The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort","volume":"113","author":"Warners","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.iac.2023.12.011_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo","year":"2017","journal-title":"United European Gastroenterol J"},{"issue":"6","key":"10.1016\/j.iac.2023.12.011_bib12","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","article-title":"Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner","volume":"145","author":"Schoepfer","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.iac.2023.12.011_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cgh.2008.02.003","article-title":"Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients","volume":"6","author":"Straumann","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.iac.2023.12.011_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s40265-019-01173-2","article-title":"Pharmacotherapies for the treatment of eosinophilic esophagitis: state of the art review","volume":"79","author":"de Rooij","year":"2019","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.iac.2023.12.011_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14656566.2022.2060077","article-title":"Drug treatment strategies for eosinophilic esophagitis in adults","volume":"23","author":"Lucendo","year":"2022","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.iac.2023.12.011_bib16","unstructured":"FDA approves first treatment for eosinophilic esophagitis, a chronic immune disorder. News release. U.S. Food and Drug Administration. 2022. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-eosinophilic-esophagitis-chronic-immune-disorder. Accessed June 25, 2022."},{"issue":"2","key":"10.1016\/j.iac.2023.12.011_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jaci.2021.07.001","article-title":"Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)","volume":"149","author":"Ma","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2023.12.011_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2050640617707095","article-title":"Determinant factors of quality of life in adult patients with eosinophilic esophagitis","volume":"6","author":"Lucendo","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.iac.2023.12.011_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820980860","article-title":"Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults","volume":"14","author":"Visaggi","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"issue":"6","key":"10.1016\/j.iac.2023.12.011_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/nmo.12323","article-title":"Disease duration determines health-related quality of life in adult eosinophilic esophagitis patients","volume":"26","author":"van Rhijn","year":"2014","journal-title":"Neuro Gastroenterol Motil"},{"issue":"3","key":"10.1016\/j.iac.2023.12.011_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5056\/jnm21143","article-title":"General well-being and coping strategies in adult eosinophilic esophagitis patients","volume":"28","author":"de Rooij","year":"2022","journal-title":"J\u00a0Neurogastroenterol Motil"},{"issue":"10","key":"10.1016\/j.iac.2023.12.011_bib22","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1007\/s10620-020-06719-z","article-title":"Generic measures of quality of life are not correlated with disease activity in eosinophilic esophagitis","volume":"66","author":"Chang","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.iac.2023.12.011_bib23","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1007\/s00405-015-3696-4","article-title":"Dysphagia and health-related quality of life in patients with eosinophilic esophagitis: a long-term follow-up","volume":"272","author":"Larsson","year":"2015","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"9","key":"10.1016\/j.iac.2023.12.011_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/MCG.0b013e3182166a5a","article-title":"Qualitative assessment of patient-reported outcomes in adults with eosinophilic esophagitis","volume":"45","author":"Taft","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.iac.2023.12.011_bib25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2036.2011.04791.x","article-title":"The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life","volume":"34","author":"Taft","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.iac.2023.12.011_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/dox128","article-title":"Prospective assessment of disease-specific quality of life in adults with eosinophilic esophagitis","volume":"31","author":"Stern","year":"2018","journal-title":"Dis Esophagus"},{"issue":"2 Supplement","key":"10.1016\/j.iac.2023.12.011_bib27","doi-asserted-by":"crossref","first-page":"AB91","DOI":"10.1016\/j.jaci.2020.12.347","article-title":"Dupilumab improves health-related quality of life (HRQoL) and reduces symptom burden in patients with eosinophilic esophagitis (EoE): results from part a of a randomized, placebo-controlled three-part phase 3 study","volume":"147","author":"Dellon","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"25","key":"10.1016\/j.iac.2023.12.011_bib28","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","article-title":"Dupilumab in adults and adolescents with eosinophilic esophagitis","volume":"387","author":"Dellon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iac.2023.12.011_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/ajg.2016.20","article-title":"Development of the northwestern esophageal quality of life scale: a hybrid measure for use across esophageal conditions","volume":"111","author":"Bedell","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.iac.2023.12.011_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1542-3565(04)00349-0","article-title":"Responsiveness and interpretation of a quality of life questionnaire specific to upper gastrointestinal disorders","volume":"2","author":"De La Loge","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.iac.2023.12.011_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/apt.12119","article-title":"The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood","volume":"37","author":"Menard-Katcher","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.iac.2023.12.011_bib32","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0959-8049(03)00270-3","article-title":"Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer","volume":"39","author":"Blazeby","year":"2003","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.iac.2023.12.011_bib33","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/apt.13370","article-title":"Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity","volume":"42","author":"Safroneeva","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.iac.2023.12.011_bib34","first-page":"1","article-title":"Effects of eosinophilic oesophagitis on quality of life in an adult UK population: a case control study","volume":"30","author":"Hewett","year":"2017","journal-title":"Dis Esophagus"},{"issue":"8","key":"10.1016\/j.iac.2023.12.011_bib35","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cgh.2021.11.009","article-title":"Sex impacts disease activity but not symptoms or quality of life in adults with eosinophilic esophagitis","volume":"20","author":"Schreiner","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.iac.2023.12.011_bib36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1053\/j.gastro.2021.06.023","article-title":"Esophageal hypervigilance and symptom-specific anxiety in patients with eosinophilic esophagitis","volume":"161","author":"Taft","year":"2021","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.iac.2023.12.011_bib37","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","article-title":"Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis","volume":"146","author":"Arias","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.iac.2023.12.011_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12016-017-8660-1","article-title":"Dietary Therapy for Eosinophilic Esophagitis: Elimination and Reintroduction","volume":"55","author":"Kliewer","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"10.1016\/j.iac.2023.12.011_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/nu14081588","article-title":"Nutritional and psychological considerations for dietary therapy in eosinophilic esophagitis","volume":"14","author":"Molina-Infante","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.iac.2023.12.011_bib40","doi-asserted-by":"crossref","first-page":"820192","DOI":"10.3389\/fped.2021.820192","article-title":"Diet therapy in eosinophilic esophagitis. focus on a personalized approach","volume":"9","author":"Votto","year":"2021","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.iac.2023.12.011_bib41","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s10620-018-5045-0","article-title":"Assessing adherence and barriers to long-term elimination diet therapy in adults with eosinophilic esophagitis","volume":"63","author":"Wang","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.iac.2023.12.011_bib42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S2468-1253(23)00012-2","article-title":"One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.iac.2023.12.011_bib43","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/j.gastro.2012.03.001","article-title":"Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors","volume":"142","author":"Gonsalves","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.iac.2023.12.011_bib44","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cgh.2021.05.049","article-title":"Long-lasting dissociation of esophageal eosinophilia and symptoms after dilation in adults with eosinophilic esophagitis","volume":"20","author":"Safroneeva","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.iac.2023.12.011_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.iac.2023.12.011_bib46","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.iac.2023.12.011_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(23)00204-2","article-title":"Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","author":"Rothenberg","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.iac.2023.12.011_bib48","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/apt.15000","article-title":"Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes","volume":"48","author":"Safroneeva","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.iac.2023.12.011_bib49","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.14309\/ajg.0000000000001850","article-title":"Poor adherence to medical and dietary treatments in adult patients with eosinophilic esophagitis","volume":"117","author":"Haasnoot","year":"2022","journal-title":"Am J Gastroenterol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856123001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856123001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T01:25:22Z","timestamp":1729128322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856123001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0889856123001145"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2023.12.011","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-Related Quality of Life in Patients with Eosinophilic Esophagitis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2023.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}